100s of titles, one news app for just $10 a month.
Dive Deeper:
Pieris Pharmaceuticals's Earnings Outlook
Pieris Pharmaceuticals (NASDAQ:PIRS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Recap: CASI Pharmaceuticals Q1 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Recap: Reata Pharmaceuticals Q1 Earnings
Reata Pharmaceuticals (NASDAQ:RETA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need…
Recap: Xenon Pharmaceuticals Q1 Earnings
Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Recap: Fusion Pharmaceuticals Q1 Earnings
Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need…
Recap: Collegium Pharmaceutical Q1 Earnings
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
Get all your news in one place
Latest Business news:
Jeff Bezos Lashes Out at Joe Biden and The Democrats
Amazon founder had previously avoided public tussles with the federal government.
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Renault hands Russian assets to Moscow
Moscow (AFP) - French automaker Renault has handed over its Russian assets to the Russian government, both parties announced Monday,…
First Default on Foreign Debt Likely This Week: Sri Lanka Latest
Sri Lanka is sliding into a default as the grace period on two unpaid foreign bonds ends on Wednesday, the…
Bitcoin recovers above $30,000, other crypto prices today also surge; Terra cracks 31%
Cryptocurrency Bitcoin staged a modest recovery and was up more than 2%
Elon Musk Takes a Stand in Controversial Disney Copyright Case
The copyright debate has recently been revived by a bill seeking to reduce the term of protection for original works.
From analysis to good news, read the world’s best news in one place
Facebook changing with times a decade after stock debut
San Francisco (AFP) - Facebook boss Mark Zuckerberg rang the opening bell remotely to cheers 10 years ago as the…
WA craft brewer Boston Brewery creates wet hop beers to help sustain farms
WA craft brewers are experimenting with wet hop beers that can only be made using freshly harvested, local hops. It…

Recap: Pieris Pharmaceuticals Q1 Earnings

By Benzinga Insights

 

Pieris Pharmaceuticals (NASDAQ:PIRS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Pieris Pharmaceuticals beat estimated earnings by 36.36%, reporting an EPS of $-0.07 versus an estimate of $-0.11.

Revenue was down $4.64 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 3.26% increase in the share price the next day.

Here's a look at Pieris Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.30 -0.24 -0.26 -0.17
EPS Actual -0.13 -0.24 -0.25 -0.07
Revenue Estimate 2.45M 5.32M 2.07M 6.47M
Revenue Actual 8.44M 4.06M 3.29M 15.63M

To track all earnings releases for Pieris Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Pieris Pharmaceuticals's Earnings Outlook
Pieris Pharmaceuticals (NASDAQ:PIRS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Recap: CASI Pharmaceuticals Q1 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Recap: Reata Pharmaceuticals Q1 Earnings
Reata Pharmaceuticals (NASDAQ:RETA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need…
Recap: Xenon Pharmaceuticals Q1 Earnings
Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
One subscription that gives you access to news from hundreds of sites
Recap: Fusion Pharmaceuticals Q1 Earnings
Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need…
Recap: Collegium Pharmaceutical Q1 Earnings
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need…
Get all your news in one place